Applicant, as named in the Orange Book

Currax

Next listed expiry: Silenor on 7 Sep 2030. 1 products with live protection, 0 without.

Products with listed protection

Drug	Ingredient	NDA	Earliest generic entry	Basis
Silenor · 2 strengths doxepin hydrochloride	doxepin hydrochloride	022036	7 Sep 2030	patent, carve-out possible

No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.